Overview

Levosimendan in Acute Kidney Injury Study

Status:
Unknown status
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
We hypothesise that levosimendan will have a positive influence on renal function during acute kidney injury in adult intensive care patients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
VieCuri Medical Centre
Collaborator:
Orion Corporation, Orion Pharma
Treatments:
Simendan